Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
215 studies found for:    "Meningococcal infection"
Show Display Options
Rank Status Study
1 Completed Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection
Condition: Meningococcal Infections
Intervention:
2 Recruiting Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)
Condition: Meningococcal Infections
Intervention: Biological: Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals)
3 Completed Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections;   Invasive Meningococcal Disease
Interventions: Biological: MenACYW Conjugate Vaccine;   Biological: Meningococcal Polysaccharide Vaccine Groups A, C, Y, W 135 Combined
4 Active, not recruiting Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
5 Enrolling by invitation Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
6 Completed
Has Results
Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age
Conditions: Meningitis;   Meningococcal Infection;   Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae Serotype b (Hib)
Interventions: Biological: Meningococcal polysaccharide diphtheria toxoid conjugate;   Biological: Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed;   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate
7 Completed
Has Results
Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®
8 Completed
Has Results
Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations
Conditions: Meningitis;   Meningococcal Infection
Interventions: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®;   Biological: Meningococcal Group C Conjugate vaccine: MenC
9 Completed
Has Results
A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India
Conditions: Meningococcal Infection;   Meningitis
Intervention: Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate (Menactra®)
10 Completed A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Conditions: Meningitis;   Meningococcal Infection
Interventions: Biological: Meningococcal Polysaccharide Tetanus Protein Conjugate;   Biological: Pentacel®;   Biological: M-M-R®II;   Biological: Varivax®;   Biological: Prevnar®;   Biological: RotaTeq®;   Biological: Engerix-B®
11 Completed
Has Results
Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
12 Completed
Has Results
Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Polysaccharide Diphtheria Conjugate Vaccine
13 Recruiting Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
14 Active, not recruiting Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine;   Biological: Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W 135 Combined
15 Active, not recruiting Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine;   Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
16 Active, not recruiting Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine;   Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
17 Recruiting Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
18 Recruiting Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
19 Completed Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
20 Active, not recruiting Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years